used in standard Chinese, Ayurvedic, and Thai medication. Conolidine could represent the start of a new era of Persistent pain management. It is currently getting investigated for its effects around the atypical chemokine receptor (ACK3). In the rat product, it was located that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3�